CAJ | 학술논문

近年来肾移植后新发糖尿病（ NODAT）已经成为影响移植物和患者长期生存率的第二大因素，仅次于急慢性排斥反应。其多发生在移植后1年内，这主要与第1年免疫抑制剂的剂量相对较大有关，也与患者年龄、肥胖、肝功能等其他危险因素有关。对NODAT的有效控制，在落实预防措施的同时，离不开护理干预。本文就国内外对NODAT的危险因素及护理干预研究进展进行综述。
근년래신이식후신발당뇨병（ NODAT）이경성위영향이식물화환자장기생존솔적제이대인소，부차우급만성배척반응。기다발생재이식후1년내，저주요여제1년면역억제제적제량상대교대유관，야여환자년령、비반、간공능등기타위험인소유관。대NODAT적유효공제，재락실예방조시적동시，리불개호리간예。본문취국내외대NODAT적위험인소급호리간예연구진전진행종술。
The new-onset diabetes mellitus after transplantation ( NODAT) has become the major risk factor that affects both graft and patient survival , which is secondary to acute/chronic rejection .The NODAT mostly attacks within the first year after transplantation , which is mainly associated with high dose of immunosuppress drug , patients ’ age, obesity and abnormal liver function .To control NODAT efficiently , nursing intervention is needed in spite of medical prophylaxis .This review will focus on the international research development of risk factors and the relevant nursing intervention of NODAT .